Knowing that naloxone works by stalling the µ-opioid receptor in an early, latent state suggests that molecules that can bind more tightly or more selectively to this form of the receptor could be ...
Nuvectis Pharma, Inc. (NASDAQ: NVCT, the “Company”), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of ...
In an effort to reveal the inner workings of a protein that serves as a cell's damage detection system, scientists at Johns ...
Stockhead on MSN
Biocurious: Cochlear-backed Epiminder strives to raise the bar on epilepsy monitoring
Having raised $125 million, the Cochlear-based Epiminder lists next Monday on the back of its groundbreaking epilepsy ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...
At United Nations climate talks billed widely as having a special focus on Indigenous people, those people themselves have ...
In an email to federal members of parliament, Association of independently Owned Financial Professionals (AIOFP) executive ...
Amid rising geopolitical tensions, the EU and Japan intensify joint supply-chain monitoring, critical technologies protection, and coordinated investment screening to strengthen their shared economic ...
Pete Whittington discusses efforts to restore metal-contaminated peatlands in Sudbury, Ontario, which were affected by mining ...
Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise November 24, 2025 9:00 AM ...
In an effort to reveal the inner workings of a protein that serves as a cell’s damage detection system, scientists at Johns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback